JP2015506179A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015506179A5 JP2015506179A5 JP2014554791A JP2014554791A JP2015506179A5 JP 2015506179 A5 JP2015506179 A5 JP 2015506179A5 JP 2014554791 A JP2014554791 A JP 2014554791A JP 2014554791 A JP2014554791 A JP 2014554791A JP 2015506179 A5 JP2015506179 A5 JP 2015506179A5
- Authority
- JP
- Japan
- Prior art keywords
- point mutation
- amino acid
- acid sequence
- polynucleotide
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261590089P | 2012-01-24 | 2012-01-24 | |
| US61/590,089 | 2012-01-24 | ||
| PCT/US2013/022696 WO2013112549A1 (en) | 2012-01-24 | 2013-01-23 | Polynucleotides for treating oncogenic viral polypeptide positive tumors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017188121A Division JP6655051B2 (ja) | 2012-01-24 | 2017-09-28 | 発癌性ウイルスポリペプチド陽性腫瘍治療用ポリヌクレオチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015506179A JP2015506179A (ja) | 2015-03-02 |
| JP2015506179A5 true JP2015506179A5 (enExample) | 2016-03-10 |
| JP6219849B2 JP6219849B2 (ja) | 2017-10-25 |
Family
ID=48873849
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014554791A Active JP6219849B2 (ja) | 2012-01-24 | 2013-01-23 | 発癌性ウイルスポリペプチド陽性腫瘍治療用ポリヌクレオチド |
| JP2017188121A Active JP6655051B2 (ja) | 2012-01-24 | 2017-09-28 | 発癌性ウイルスポリペプチド陽性腫瘍治療用ポリヌクレオチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017188121A Active JP6655051B2 (ja) | 2012-01-24 | 2017-09-28 | 発癌性ウイルスポリペプチド陽性腫瘍治療用ポリヌクレオチド |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9492526B2 (enExample) |
| EP (2) | EP2806889B1 (enExample) |
| JP (2) | JP6219849B2 (enExample) |
| KR (1) | KR102195196B1 (enExample) |
| CN (2) | CN104159607A (enExample) |
| DK (1) | DK2806889T3 (enExample) |
| ES (1) | ES2646590T3 (enExample) |
| HK (1) | HK1203833A1 (enExample) |
| IN (1) | IN2014DN06118A (enExample) |
| WO (1) | WO2013112549A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS60937B1 (sr) | 2014-11-13 | 2020-11-30 | Univ Geneve | Tri-segmentirani arenavirusi kao vektori za vakcinu |
| CN115197965A (zh) | 2015-06-10 | 2022-10-18 | 霍欧奇帕生物科技有限公司 | Hpv疫苗 |
| CN108779472B (zh) | 2015-11-04 | 2022-09-09 | 霍欧奇帕生物科技有限公司 | 针对乙型肝炎病毒的疫苗 |
| EP3373959B1 (en) | 2015-11-12 | 2022-06-29 | Hookipa Biotech GmbH | Arenavirus particles as cancer vaccines |
| KR102833333B1 (ko) | 2016-01-08 | 2025-07-11 | 니코데 테라퓨틱스 에이에스에이 | 치료적 항암 네오에피토프 백신 |
| GB201605210D0 (en) | 2016-03-29 | 2016-05-11 | Oxford Immunotec Ltd | Assay |
| EP3463577A4 (en) * | 2016-06-03 | 2019-12-04 | Etubics Corporation | COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH HUMAN PAPILLOMVIRUS (HPV) |
| CN106655327A (zh) * | 2016-10-18 | 2017-05-10 | 云南中烟工业有限责任公司 | 一种压缩式充电装置 |
| CN117370603A (zh) | 2016-11-11 | 2024-01-09 | 谷歌有限责任公司 | 基于用户装置的消费模式来修改视频内容在用户装置上的呈现的方法、系统和介质 |
| US12404306B2 (en) | 2018-03-06 | 2025-09-02 | Precigen, Inc. | Human papillomavirus vaccines and uses of the same |
| EP4121567B1 (en) * | 2020-03-16 | 2025-12-31 | The University of North Carolina at Chapel Hill | COMPOSITIONS AND METHODS FOR THE SELECTIVE DETECTION OF TUMOR-DERIVED VIRAL DNA |
| KR102712588B1 (ko) * | 2020-05-25 | 2024-10-02 | (주)진매트릭스 | 사람 파필로마바이러스의 구조적으로 변형된 키메라 폴리펩타이드 및 그 폴리펩타이드를 포함하는 재조합 단백질 및 그 단백질의 용도 |
| CA3178325A1 (en) * | 2020-05-25 | 2021-12-02 | Soo Ok Kim | Structurally modified chimeric polypeptide of human papillomavirus, recombinant protein comprising same polypeptide, and use of same protein |
| CN116425839A (zh) * | 2023-04-03 | 2023-07-14 | 深圳锦时生物科技有限公司 | 人乳头瘤病毒多肽及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9717953D0 (en) * | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| ATE283915T1 (de) * | 1998-05-26 | 2004-12-15 | Inst Of Molecul & Cell Biology | Polypeptide aus dem creb-bindenden protein und verwandten protein p-300 zur verwendung bei der transkriptionellen regulation |
| US7223408B2 (en) | 2002-10-03 | 2007-05-29 | Wyeth Holdings Corporation | Human papillomavirus polypeptides and immunogenic compositions |
| BRPI0810305A2 (pt) * | 2007-05-15 | 2018-07-10 | Transgene Sa | "vetor, molécula de ácido nucléico substancialmente isolada, célula hospedeira, composição farmacêutica, uso de uma molécula de ácido nucléico, uso de um vetor, uso de uma célula hospedeira e uso de uma composição" |
| US20120244173A1 (en) * | 2009-04-28 | 2012-09-27 | Tzyy-Choou Wu | Compositions and Methods for Enhancing Antigen-Specific Immune Responses |
| CN102002105B (zh) * | 2009-09-03 | 2013-01-23 | 中国疾病预防控制中心病毒病预防控制所 | Hpv 16型e7e6融合蛋白基因、表达载体、方法、细胞和用途 |
-
2013
- 2013-01-23 JP JP2014554791A patent/JP6219849B2/ja active Active
- 2013-01-23 DK DK13740950.4T patent/DK2806889T3/da active
- 2013-01-23 WO PCT/US2013/022696 patent/WO2013112549A1/en not_active Ceased
- 2013-01-23 CN CN201380012419.2A patent/CN104159607A/zh active Pending
- 2013-01-23 EP EP13740950.4A patent/EP2806889B1/en active Active
- 2013-01-23 HK HK15104469.7A patent/HK1203833A1/xx unknown
- 2013-01-23 US US14/373,844 patent/US9492526B2/en active Active
- 2013-01-23 CN CN201910216555.2A patent/CN110042110A/zh active Pending
- 2013-01-23 EP EP17185609.9A patent/EP3269387B1/en active Active
- 2013-01-23 KR KR1020147023589A patent/KR102195196B1/ko active Active
- 2013-01-23 IN IN6118DEN2014 patent/IN2014DN06118A/en unknown
- 2013-01-23 ES ES13740950.4T patent/ES2646590T3/es active Active
-
2016
- 2016-09-06 US US15/257,198 patent/US9969779B2/en active Active
-
2017
- 2017-09-28 JP JP2017188121A patent/JP6655051B2/ja active Active
-
2018
- 2018-04-11 US US15/950,819 patent/US20180237477A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2848064T3 (es) | Vacuna terapéutica potenciadora de inmunidad para VPH y enfermedades relacionadas | |
| Pol et al. | Trial watch: oncolytic viruses for cancer therapy | |
| ES3041285T3 (en) | A vaccine for use in the prophylaxis and/or treatment of a disease | |
| AU2014221143B2 (en) | Vaccine composition | |
| JP2016539946A5 (enExample) | ||
| CN121534168A (zh) | 癌疫苗及使用其的治疗方法 | |
| US9492526B2 (en) | Polynucleotides for treating oncogenic viral polypeptide positive tumors | |
| JP2016513115A5 (enExample) | ||
| JP2020528911A5 (enExample) | ||
| JP2018536002A5 (enExample) | ||
| JP2024505274A (ja) | ワクチン接種中のｔ細胞プライミングの強化において使用されるウイルスコンストラクト | |
| RU2018123307A (ru) | Вакцинация с использованием альфа3 домена mica/b для лечения рака | |
| AU2017264901A1 (en) | Combination prime: boost therapy | |
| JP2017522326A5 (enExample) | ||
| JP2021500880A5 (enExample) | ||
| JP7737141B2 (ja) | 細胞融合を誘導するワクシニアウイルス及びその利用 | |
| JP2017516462A5 (enExample) | ||
| CN102000330B (zh) | 一种核酸疫苗佐剂及其构建方法 | |
| RU2020100072A (ru) | Иммуногенные композиции, содержащие cea, muc1 и tert | |
| WO2024198943A1 (en) | Homologous and heterologous therapeutic vaccination strategies for cancer treatment | |
| RU2024128257A (ru) | Общие неоантигены | |
| CD et al. | Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack | |
| JP2016032439A (ja) | Ｈｔｌｖ−１関連疾患の予防及び／又は治療用ワクチン | |
| Golin | A Cure for Cancer | |
| Choi et al. | 129. Oncolytic Adenovirus Expressing IL-23 and p35 Elicits IFN-γ-and TNF-a-Co-Producing T Cell-Mediated Antitumor Immunity |